New safety information emerges from postmarketing use of ritonavir.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D006801:Humans; D011358:Product Surveillance, Postmarketing; D019438:Ritonavir / Q000009:adverse effects*
D019380:Anti-HIV Agents; D019438:Ritonavir